Strategic partnerships RxResults has a history of collaborative partnerships with healthcare and pharmacy organizations, including a long-standing relationship with University of Arkansas for Medical Sciences College of Pharmacy and past ties with EBRx and Tabula Rasa HealthCare. This suggests a fertile pathway for co-development opportunities and expanded service offerings with large health networks and tech-enabled pharmacy platforms.

Evidence based Positioned as an industry leader in Evidence-Based Pharmacy Risk Management, RxResults provides a differentiating capability focused on safe, effective medication use with cost control. This creates a strong upsell opportunity to health plans and PBMs seeking proven methodologies to mitigate medication risk while preserving access.

Growth potential With revenue disclosed in the $25M-$50M range and ongoing collaborations with innovative health tech players, there is clear scale potential for expanding contract sizes or expanding to additional markets with similar risk management needs, especially targeting mid-sized plans that align with their capabilities.

Tech enabled RxResults leverages a modern tech stack including Salesforce, WordPress, Google Cloud and other tools, indicating readiness for deeper digital engagement, data integration, and scalable analytics services that can be packaged into enterprise deployments for health plans.

Competitive landscape Operating in a market with peers such as ArroHealth, Navitus and Prime Therapeutics, RxResults can position itself as a specialty risk management partner for plans seeking evidence-based savings. Opportunities include targeting mid-market plans looking for proven models and leveraging partner ecosystem connections.